{"id":1031054,"date":"2013-01-15T16:02:25","date_gmt":"2013-01-15T16:02:25","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/human-reproduction\/guideline-adherence-is-worth-the-effort-a-cost-effectiveness-analysis-in-intrauterine-insemination-care.php"},"modified":"2024-08-17T15:03:00","modified_gmt":"2024-08-17T19:03:00","slug":"guideline-adherence-is-worth-the-effort-a-cost-effectiveness-analysis-in-intrauterine-insemination-care","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/guideline-adherence-is-worth-the-effort-a-cost-effectiveness-analysis-in-intrauterine-insemination-care.php","title":{"rendered":"Guideline adherence is worth the effort: a cost-effectiveness analysis in intrauterine insemination care"},"content":{"rendered":"<p>STUDY QUESTION<\/p>\n<p>Is optimal adherence to guideline recommendations in intrauterine insemination (IUI) care cost-effective from a societal perspective when compared with suboptimal adherence to guideline recommendations?<\/p>\n<p>SUMMARY ANSWER<\/p>\n<p>Optimal guideline adherence in IUI care has substantial economic benefits when compared with suboptimal guideline adherence.<\/p>\n<p>WHAT IS KNOWN ALREADY<\/p>\n<p>Fertility guidelines are tools to help health-care professionals, and patients make better decisions about clinically effective, safe and cost-effective care. Up to now, there has been limited published evidence about the association between guideline adherence and cost-effectiveness in fertility care.<\/p>\n<p>STUDY DESIGN, SIZE, DURATION<\/p>\n<p>In a retrospective cohort study involving medical record analysis and a patient survey (<I>n<\/I> = 415), interviews with staff members (<I>n<\/I> = 13) and a review of hospitals' financial department reports and literature, data were obtained about patient characteristics, process aspects and clinical outcomes of IUI care and resources consumed. In the cost-effectiveness analyses, restricted to four relevant guideline recommendations, the ongoing pregnancy rate per couple (effectiveness), the average medical and non-medical costs of IUI care, possible additional IVF treatment, pregnancy, delivery and period from birth up to 6 weeks after birth for both mother and offspring per couple (costs) and the incremental net monetary benefits were calculated to investigate if optimal guideline adherence is cost-effective from a societal perspective when compared with suboptimal guideline adherence.<\/p>\n<p>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/p>\n<p>Seven hundred and sixty five of 1100 randomly selected infertile couples from the databases of the fertility laboratories of 10 Dutch hospitals, including 1 large university hospital providing tertiary care and 9 public hospitals providing secondary care, were willing to participate, but 350 couples were excluded because of ovulatory disorders or the use of donated spermatozoa (<I>n<\/I> = 184), still ongoing IUI treatment (<I>n<\/I> = 143) or no access to their medical records (<I>n<\/I> = 23). As a result, 415 infertile couples who started a total of 1803 IUI cycles were eligible for the cost-effectiveness analyses.<\/p>\n<p>MAIN RESULTS AND THE ROLE OF CHANCE<\/p>\n<p>Optimal adherence to the guideline recommendations about sperm quality, the total number of IUI cycles and dose of human chorionic gonadotrophin was cost-effective with an incremental net monetary benefit between  645 and over  7500 per couple, depending on the recommendation and assuming a willingness to pay  20 000 for an ongoing pregnancy.<\/p>\n<p>LIMITATIONS, REASONS FOR CAUTION<\/p>\n<p>Because not all recommendations applied to all 415 included couples, smaller groups were left for some of the cost-effectiveness analyses, and one integrated analysis with all recommendations within one model was impossible.<\/p>\n<p>WIDER IMPLICATIONS OF THE FINDINGS<\/p>\n<p>Optimal guideline adherence in IUI care has substantial economic benefits when compared with suboptimal guideline adherence. For Europe, where over 144 000 IUI cycles are initiated each year to treat ~32 000 infertile couples, this could mean a possible cost saving of at least 20 million euro yearly. Therefore, it is valuable to make an effort to improve guideline development and implementation.<\/p>\n<p>STUDY FUNDING\/COMPETING INTEREST(S)<\/p>\n<p>This study was supported financially by the Netherlands Organisation for Health Research and Development, Grant No. 945-12-012, The Hague, The Netherlands. The funding source had no involvement in the study. The authors declare that they have no conflict of interest.<\/p>\n<p>Source:<br \/><a href=\"http:\/\/humrep.oxfordjournals.org\/cgi\/content\/short\/28\/2\/357?rss=1\">http:\/\/humrep.oxfordjournals.org\/cgi\/content\/short\/28\/2\/357?rss=1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STUDY QUESTION Is optimal adherence to guideline recommendations in intrauterine insemination (IUI) care cost-effective from a societal perspective when compared with suboptimal adherence to guideline recommendations? SUMMARY ANSWER Optimal guideline adherence in IUI care has substantial economic benefits when compared &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/guideline-adherence-is-worth-the-effort-a-cost-effectiveness-analysis-in-intrauterine-insemination-care.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246857],"tags":[],"class_list":["post-1031054","post","type-post","status-publish","format-standard","hentry","category-human-reproduction"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1031054"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1031054"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1031054\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1031054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1031054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1031054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}